Home > Healthcare > Medical Devices > Diagnostic Devices > Hepatitis Diagnostic Tests Market

Hepatitis Diagnostic Tests Market Size

  • Report ID: GMI5626
  • Published Date: May 2023
  • Report Format: PDF

Hepatitis Diagnostic Tests Market Size

Hepatitis Diagnostic Tests Market size was valued at around USD 3.4 billion in 2022 and is projected to witness over 5.8% CAGR from 2023 to 2032. Increasing prevalence of hepatitis is expected to augment the market growth.

 

Rising awareness regarding availability of several diagnostic tests for hepatitis screening has surged the market progress. Technological advancements pertaining to these diagnostic tests have fuelled the screening of blood sample, thereby resulting in better diagnosis and treatment. Availability of advanced detection techniques such as molecular diagnostics, nucleic acid assays, rapid diagnostic tests (RDTs) etc. is spurring the overall market revenue.

 

Hepatitis diagnostic tests are medical tests intended to detect the presence of hepatitis viruses and evaluate the extent of inflammation or damage of the liver caused by the virus. These tests detect antibodies or antigens associated with different types of hepatitis and measure various enzymes and proteins produced by the liver.

 

Limited access to reliable and low-cost hepatitis diagnostic tests is a major public health concern. Moreover, this limited access is a major constraint particularly in resource-limited healthcare facilities. Hepatitis is a major cause of liver disease and can have serious long-term health consequences if left untreated. However, the cost of diagnostic tests, particularly for hepatitis B and C, can be excessively high and testing may not be available for patients in developing countries. Growing concern pertaining to the rising costs of these test is further compounded by the increasing demand for hepatitis screening in blood, thereby requiring these kits and devices for diagnosis.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for hepatitis diagnostic tests was around USD 3.4 billion in 2022 and will record a 5.8% CAGR between 2023 to 2032.

Reagents & kits was USD 2.3 billion in 2022 owing to benefits offered by kits and reagents in precise & accurate screening of hepatitis disease.

Abbott Laboratories, Autobio Diagnostics, Analytik Jena, DiaSorin, Grifols SA, Danher Corporation, Roche Molecular Diagnostics, Hologic Inc., MedMira Inc, and Ortho-Clinical Diagnostics are the top companies in the global market.

North America hepatitis diagnostic tests market size was about USD 1.4 billion in 2022 and is anticipated to expand due to growing prevalence of hepatitis and related chronic diseases across the region.

Hepatitis Diagnostic Tests Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 520
  • Countries covered: 30
  • Pages: 185
 Download Free Sample